Search Result "ldl modification"
Electronegative LDL: An Active Player in Atherogenesis or a By- Product of Atherosclerosis?
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1665-1679
Author(s): Andrea Rivas-Urbina,Anna Rull,Jordi Ordóñez-Llanos,José Luis Sánchez-Quesada
Prostaglandins and Lipid Modification
Journal: Current Pharmaceutical Design
Volume: 7 Issue: 6 Year: 2001 Page: 461-474
Author(s): Grazyna Sobal, H. Sinzinger
Modified LDL Immune Complexes and Cardiovascular Disease
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1680-1692
Author(s): Maria F. Lopes-Virella,Gabriel Virella
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Role of Ox-LDL and LOX-1 in Atherogenesis
Journal: Current Medicinal Chemistry
Volume: 26 Issue: 9 Year: 2019 Page: 1693-1700
Author(s): Ajoe John Kattoor,Sri Harsha Kanuri,Jawahar L. Mehta
LDL and HDL Subfractions, Dysfunctional HDL: Treatment Options
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 6249-6255
Author(s): Antonio Garcia-Rios, Dragana Nikolic, Pablo Perez-Martinez, Jose Lopez-Miranda, Manfredi Rizzo, Ron C. Hoogeveen
Misfolding of Apoprotein B-100, LDL Aggregation and 17-β -estradiol in Atherogenesis
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 20 Year: 2014 Page: 2276-2283
Author(s): R. Brunelli,M. De Spirito,G. Mei,M. Papi,G. Perrone,C. Stefanutti,T. Parasassi
Rapid and Simple Profiling of Lipoproteins by Polyacrylamide-Gel Disc Electrophoresis to Determine the Heterogeneity of Low-Density Lipoproteins (LDLs) Including Small, Dense LDL
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 4 Issue: 1 Year: 2009 Page: 31-36
Author(s): Takanari Nakano, Ikuo Inoue, Makoto Seo, Seiichiro Takahashi, Takuya Awata, Tsugikazu Komoda, Shigehiro Katayama
Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease
Journal: Current Drug Delivery
Volume: 18 Issue: 7 Year: 2021 Page: 1027-1040
Author(s): Md Masum Rizwee,Minhal Abidi,Safia Habib,Abdul Rouf Mir,Asif Ali,Moin Uddin
Retrospective, Observation Study: Quantitative and Qualitative Effect of Ezetimibe and HMG-CoA Reductase Inhibitors on LDL-Cholesterol: Are There Disappearance Thresholds for Small, Dense LDL and IDL?
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 5 Issue: 2 Year: 2010 Page: 143-152
Author(s): Ikuo Inoue, Takuya Awata, Shigehiro Katayama